Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACIP Chairman Ownership Of Merck Stock Challenged By Rep. Burton

Executive Summary

Stock ownership by advisory committee members discussing a competing product should be considered a conflict of interest, House Committee for Government Reform Chair Burton (R-Ind.) said at a June 15 hearing regarding conflicts of interest in vaccine reviews.

You may also be interested in...



Rep. Burton May Subpoena HHS Officials’ Financial Records On Vaccines

HHS officials' financial records may be subpoenaed by Rep. Dan Burton (R-Ind.) in an effort to disclose possible financial ties between pharmaceutical companies and government health agencies

Rep. Burton May Subpoena HHS Officials’ Financial Records On Vaccines

HHS officials' financial records may be subpoenaed by Rep. Dan Burton (R-Ind.) in an effort to disclose possible financial ties between pharmaceutical companies and government health agencies

Vaccine Injury Expert Witnesses Should Make Financial Disclosure – Burton

Expert witnesses in vaccine injury compensation trials should be required to provide financial disclosure statements, House Government Reform Committee Chairman Dan Burton (R-Ind.) said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036191

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel